Lipella Pharmaceuticals Inc. (LIPO) analyst actions
Rating and price-target actions on LIPO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LIPO overview →
2 measured LIPO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients | Press release | -11.19% | -37.12% | |
| Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus | Press release | +1.89% | +5.23% |
Keep exploring
More LIPO: earnings → · SEC filings → · LIPO overview →